How Long Does It Take to Lose Weight on Wegovy?

Early appetite suppression is common in the first few weeks, but the majority of weight loss occurs as doses increase over months, not days.
The STEP 1 trial reported an average reduction of roughly 15% body weight over 68 weeks at the 2.4mg maintenance dose, rising to around 20.7% at the newer 7.2mg dose over 72 weeks.
Progress is individual: starting weight, dose tolerance, diet quality, activity level and consistency all influence how quickly results appear.
Continuing treatment matters — clinical guidance recommends reviewing progress at six months; if weight loss is below 5% at the highest tolerated dose, the prescriber will discuss next steps.

Most people on Wegovy notice their appetite beginning to fall within the first one to four weeks, but meaningful, measurable weight loss typically builds over three to six months as the dose increases. In the STEP 1 clinical trial, participants lost an average of around 15% of their body weight over 68 weeks at the 2.4mg maintenance dose. That headline figure tells part of the story; the fuller picture is that weight loss on Wegovy is gradual and dose-dependent, not instant. Wegovy (semaglutide) is a prescription-only medicine: a clinician must assess your suitability before treatment can begin, and the pace at which you lose weight will depend on several factors your prescriber can help you understand.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A realistic week-by-week picture: what the evidence says about Wegovy's timeline

Step 1 — The first four to eight weeks: adjustment, not transformation

Wegovy starts at 0.25mg, a dose chosen to help your body adjust rather than to produce rapid weight loss. Nausea, mild digestive changes and reduced appetite are common at this stage. Some people notice the scales moving slightly in these early weeks, but this isn't where the bulk of progress happens, and that's by design.

The titration schedule moves upward roughly every four weeks, from 0.25mg through 0.5mg, 1mg and 1.7mg before reaching the standard 2.4mg maintenance dose. The pace is deliberate: rushing the schedule tends to worsen side effects without speeding up results. If you keep your pen in the fridge door as a reminder, you'll quickly find that dose-day becomes a quiet habit long before the numbers on the scale do anything dramatic.

The practical takeaway for these first two months: expect appetite changes, not a transformation. The treatment is working even when the weight loss feels modest. Many people find this phase the most testing, which is why clinical support through it is genuinely useful rather than optional.

Step 2, Months three to six: where most of the early weight loss happens

Once you're at or approaching the 2.4mg maintenance dose, weight loss typically accelerates. If you've been wondering how long it takes to lose weight on Wegovy, this is the phase where most of that answer becomes visible. Across the STEP 1 trial (1,961 adults, 68 weeks, published in the New England Journal of Medicine) participants had lost roughly 8 to 10 percentage points of their body weight by the six-month mark, with losses continuing beyond that.

Individual variation here is real. Starting weight, how well gastrointestinal side effects are tolerated, diet quality and physical activity all shift the curve. Someone eating a high-protein, calorie-conscious diet alongside treatment will generally see stronger results than someone making no changes at all. The NHS advises that semaglutide should be used alongside a reduced-calorie diet and increased activity, not instead of them.

For a more detailed look at what drives the timing of early results, our page on when you can expect to lose weight on Wegovy breaks down the early weeks in more depth.

Step 3, Six months to one year and beyond: maintenance dose and continued progress

NICE guidance on semaglutide for weight management notes that if a patient hasn't lost at least 5% of their body weight after six months at the highest tolerated dose, the prescriber should review whether continuing is appropriate. That threshold is a clinical checkpoint, not a failure verdict, it reflects the evidence on who benefits most from long-term treatment.

For those who do respond well, weight loss continues beyond six months, often slowing into a plateau as the body reaches a new equilibrium. The average 15% figure from STEP 1 reflects 68 weeks of treatment; the newer Wegovy 7.2mg dose, approved by the MHRA in April 2026, showed around 20.7% average weight loss over 72 weeks, approaching the results seen with tirzepatide in head-to-head data. That higher dose isn't available to everyone and requires clinical assessment, but it narrows the gap considerably for those who are suitable.

NICE recommends semaglutide for weight management for a maximum of two years under its current appraisal (NICE TA875). Long-term use beyond that, or what happens to weight after stopping, are questions best put directly to your prescriber. Our page on how long you should take Wegovy covers the duration question in full.

What slows progress, and what the evidence suggests helps

Several factors consistently show up in trial data and clinical practice as having a meaningful effect on results. Dose tolerability is one: people who can't progress past 1mg because of persistent nausea tend to see more modest losses. Adherence matters significantly, missing doses disrupts the steady-state concentration the medicine needs to work consistently. Diet composition, particularly protein adequacy, helps protect muscle mass during weight loss. And sleep quality and stress have metabolic effects that no injection overcomes entirely.

Cost is a practical factor too. If you're wondering whether the price of private treatment is worth sustaining over the months required, our Wegovy cost guide sets out what private treatment typically involves and what a transparent price should include.

Weight loss on GLP-1 medicines like Wegovy is also discussed across our broader weight loss treatment overview, which sets Wegovy in context alongside other licensed options. For those curious how the timeline compares across medicines in the same class, the semaglutide weight loss timeline page covers that angle directly.

If you're ready to discuss whether Wegovy is clinically suitable for you, a free consultation with our prescribers is the next step. A real clinician reviews every application the same day, your answers go to a person, not an algorithm.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions